Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2383593Generated: November 1, 2026

4-(4-Bromophenyl)-1-methylpiperidine → 1-Methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine

https://huagongshe.com/reaction/2383593

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-(4-Bromophenyl)-1-methylpiperidineHCID 21363877—
Reactant1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidin-4-yl acetateHCID 66730348—
SolventWaterHCID 962—
SolventEthyl AcetateHCID 8857—
Product1-Methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidineHCID 58486235—

Reaction Steps

The title compound was synthesized according to the method described for the synthesis of 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidin-4-yl acetate, except substituting 4-(4-bromophenyl)-1-methylpiperidine (236 mg, 0.93 mmol). The reaction was then allowed to cool to rt and was diluted with EtOAc and water was added. The resulting mixture was extracted with EtOAc and the combined organic extracts were washed with brine, dried over MgSO4 and concentrated to give a viscous brown solid (236 mg, used without further purification). 1H NMR (400 MHz, MeOD) δ 7.70 (d, J=7.5 Hz, 2H), 7.25 (d, J=7.5 Jz, 2H), 3.26-3.23 (m, 2H), 2.69-2.64 (m, 1H), 2.60-2.54 (m, 5H), 1.92-1.91 (m, 4H), 1.33 (s, 12H); MS ESI 302.2 [M+Na]+, calcd for [C18H28BNO2+Na]+ 302.22.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08263596B2
Source datasetuspto-grants-2012_09
ORD IDord-79590e05e9d04cc58b055dee96130dda
Source noteuspto-grants-2012_09